About Us
Dr. Ankit Agrawal
Dr. Ankit Agrawal is an MBBS, MD (TB & Respiratory Disease/Pulmonary Medicine), Interventional Pulmonologist, Critical Care, and Sleep Medicine Specialist with over 10 years of experience. He is known for his work as a Consultant in Pulmonary, Critical Care, and Sleep Medicine.
With exceptional skills in the management of Asthma, Bronchitis, Tuberculosis, COPD and many more respiratory ailments, Dr. Ankit Agrawal demonstrate a perfect blend of clinical knowledge and skills with characteristic traits of humility, compassion and empathy. Having years of experience in the medicine industry coupled with superlative knowledge and training in chest medicine procedures, he is a storehouse of scientific information. This along with suitable application knowledge he have culminated in optimal patient outcomes thus recording a high rate of patient satisfaction.
Educational Qualifications:
- MBBS – Devi Ahilya Vishwa Vidyalaya University, Indore (M.P.)
- M.D. (Pulmonary Medicine) – Teerthanker Mahaveer University, Moradabad (U.P.)
Publications:
- Research article on “Correlation of Clinical Parameters with Spirometry Findings in Patients of Chronic Obstructive Pulmonary Disease (COPD); AIMDR Journal”
Accomplishments:
- Sub-Investigator (site) - Indo-Israel DRDO Joint Research Trial-Rapid COVID Testing
- Sub-Investigator (site) of 5 Ongoing International Drug Trials for COVID
Professional Memberships:
- Indian Chest Society (ICS)
- European Respiratory Society (ERS)
- Delhi Medical Council (DMC)
- Madhya Pradesh Medical Council (MPMC)
Skill Highlights
- Ability to effectively perform patient diagnosis and management
- Good communications & counseling skills
- Competent in handling patients in Emergency, Intensive Care and Critical Care units
- Proficiency in computer applications related to work
- Sincere, proactive and dynamic individual with a flexible and result oriented attitude
Scientific Research
- Thesis on "Correlation of Clinical Severity with High Resolution Computed Tomography (HRCT) Findings in Chronic Obstructive Pulmonary Disease (COPD) Patients"
Department of Respiratory & Sleep Medicine, Aakash Healthcare Super Speciality Hospital, Dwarka, New Delhi - [2020 to 2022]
Catered to 250+ Covid patients per day during pandemic Was part of various National and International drug trials for treating covid patients
Department of Respiratory and Sleep Medicine, Medeor Super Specialty Hospital, New Delhi with Dr. J.C. Suri & Team - [2019-2020]
Independently managed OPD, IPD, ICU & performed various procedures
Teerthanker Mahaveer Medical College & Research Center, Moradabad (U.P.) M.D (Pulmonary Medicine) - Post Graduate Resident - [2016-2019]
Extensively managed OPD, IPD, Medical emergencies and Critically ill patients in the ICU
Department of Surgery, Modern Institute of Medical Sciences, Indore (M.P.) Resident [2015-2016]
Sri Aurobindo Institute of Medical Sciences, Indore (M.P.) MBBS with Internship – [2009-2015]
D5982000007 A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (KALOS)
C4671005-An Interventional Efficacy And Safety, Phase 2/3, Double-Blind, 2-Arm Study To Investigate Orally Administered Pf 07321332/Ritonavir Compared With Placebo In Non Hospitalized Symptomatic Adult Participants With Covid-19 Who Are At Increased Risk Of Progressing To Severe Iliness
CVD-19-CD-001 A Randomized, Open Label, 2-Treatment Groups Clinical Trial Evaluating the safety and efficacy of a Combination of Nitazoxanide and Hydroxychloroquine Versus Hydroxychloroquine Alone in the Acute Treatment of Moderate COVID-19 Patients.
OPEN SKIES: Use of Novel In-vitro Diagnostic Technologies (NAOR platform, Tera system BreathAnalyzer, VIRION™ test and Voice Pattern test] and RT-PCR for rapid testing of SARS-CoV2 in the Indian population
14V-MC-KHAA(d): A Randomized, Double-blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients with COVID-19 Infection
CVD-02-CD-002 # A Randomized Open Label 2- Treatment Group Clinical Trial Evaluating the Efficacy and Safety of 2- Deoxy-D-Glucose as an adjunctive therapy to standard of care, in comparison to Standard of care alone, in the Acute treatment of moderate to severe COVID 19 patients
CDFV890D12201; Phase 2, Randomized, Controlled, open label multi-center study to assess efficacy and safety of DFV890 for the treatment of SARS COV-2 infected patients with COVID-19 pneumonia and impaired respiratory functions
ATR-002-202-RESPIRE A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients with COVID-19
A Prospective, Randomized, Double-blind, Placebo controlled, Phase-II by III Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of CORBEVAX Vaccine in Children and Adolescents.
Presentation and Publication - Paper/Poster
Research article on “Correlation of Clinical Parameters with Spirometry Findings in Patients of Chronic Obstructive Pulmonary Disease (COPD); ANNALS OF INTERNATIONAL MEDICAL & DENTAL RESEARCH”
Paper presentation on “A Medical Student’s Dramatic Story: HIV Exposure to Kikuchi- Fujimoto Disease” at RESPICON INDIA 2018 in Sep 2018, Organized by Jaipur Golden Hospital, Delhi
Poster presentation on “RARE CASE OF NON-TRAUMATIC MEDIASTINAL ABSCESS MANAGED WITHOUT ANY SURGICAL INTERVENTION” in 5th North Zone Critical Care Conference SRMS PulmoCrit (ISCCM) in Oct 2018 at Jim Corbett National Park, organized by SRMS Institute of Medical Sciences, Bareilly
DIFFICULT AIRWAY & BRONCHOSCOPY COURSE conducted at 24th Annual National Conference of Indian Society of Critical Care Medicine 2018 in Mar 2018 held at BHU Varanasi, Organized by Indian Society of Critical Care Medicine (ISCCM)
NEW HORIZONS IN THORACOSCOPY conducted by Dr. PHILIPPE ASTOUL & DR. RAKESH K. CHAWLA at RESPICON INDIA 2018 in Sept 2018
Center of Excellence Non Invasive Ventilation Workshop in Sep 2018 organized by Philips India
ABG, Fluid & Electrolytes and ARDS in 5th North Zone Critical Care Conference – SRMS PulmoCrit (ISCCM) in Oct 2018 at SRMS Institute of Medical Sciences, Bareilly
Workshop on Allergy in 20th National Conference on Pulmonary Diseases – NAPCON 2018 held in Nov 2018 at Ahmedabad, Gujarat
ECHO and USG Course in ICU in 25th Annual National Conference of Indian Society of Critical Care Medicine in Jan 2019, organized by Indian Society of Critical Care Medicine
HRCT Masterclass 2021-online in association with CHEST & ACCP
• Indian Chest Society (ICS)
• European Respiratory Society (ERS)
• American College of Chest Physicians (ACCP)
• Madhya Pradesh Medical Council (MPMC)
